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Parkinson's disease (PD) is linked to aggregation of the protein a-synuclein (aS) into amyloid fibers. aS is
proposed to regulate synaptic activity and may also play a role in gene regulation via interaction with
DNA in the cell nucleus. Here, we address the role of the negatively-charged C-terminus in the inter-
action between aS and DNA using single-molecule techniques. Using nanofluidic channels, we demon-
strate that truncation of the C-terminus of aS induces differential effects on DNA depending on the extent
of the truncation. The DNA extension increases for full-length aS and the (1e119)aS variant, but de-
creases about 25% upon binding to the (1e97)aS variant. Atomic force microscopy imaging showed full
protein coverage of the DNA at high aS concentration. The characterization of biophysical properties of
DNA when in complex with aS variants may provide important insights into the role of such interactions
in PD, especially since C-terminal aS truncations have been found in clinical samples from PD patients.
© 2021 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Parkinson's disease (PD) is a neurodegenerative disease that is
estimated to affect 2% of the population older than 60 years. The
main component of the intracellular inclusions (Lewy bodies and
neurites) found in the brain of PD patients is a-synuclein (aS)
protein in an aggregated form (amyloids) [1,2]. The protein is pre-
sent mainly at synaptic terminals of the central nervous system
[3,4] and is proposed to modulate neurotransmitter vesicle recy-
cling [5e7]. The protein is monomeric at physiological conditions,
but can aggregate into amyloid fibrils at pathological conditions,
resulting in deposits as well as neuronal cell death. Mostly over-
looked, aS is also present in the cell nucleus, which appears to be
regulated by different factors, including post-translational modifi-
cations [8,9]. aS protein positioned in the nucleus can modulate the
transcription level of amastermitochondrial transcription activator
called PGC1alpha [10], and aS may also affect repair of DNA [11].
When oxidized and bound to chromatin, aS is able to promote
double-strand breaks in DNA and thereby induce cell death [12].e (F. Westerlund), pernilla.
Inc. This is an open access article uSince aS's physiological function(s) in the nucleus is not known, and
whether aS binding to DNA is related to PD initiation, more in-
vestigations of aS interacting with DNA are needed.
We recently used nanofluidic channels to investigate how aS
binding alters the physical properties of DNA [13]. Nanofluidic
channels allow stretching of single DNA molecules by confinement
and are perfectly suited for studying how proteins affect the
physical properties of DNA [14]. We demonstrated that aS binding
to DNA increases the persistence length of DNA [13]. The DNA-
protein interaction appears driven by electrostatics and, since
DNA is negatively charged, the interaction with the positively
charged N-terminal domain of aS will determine the binding to
DNA. The sequence of aS can be divided into three domains [15]:
the N-terminal region, rich in positively charged residues (12 of a
total of 16 positively charged residues) [15,16], the non-amyloid-b
component (NAC) domain (residues 61e95), which forms the core
of the amyloid fibril [4], and the C-terminus, which is rich in
negatively charged residues (15 of a total of 24 negatively charged
residues) and is proposed to be involved in protein-protein in-
teractions (Fig. 1). C-terminal truncated variants are more prone to
aggregation than full-length aS [17e21]. Importantly, C-terminal
truncated variants of aS are found in the brain of both patients with
PD and healthy individuals [22,23].
To address the role of C-terminal truncations on aS interaction
with DNA, and based on our previous study [13], we applied thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. AS sequence with the three domains and the positions of the C-terminal truncations studied here marked. The N-terminal (membrane-binding) domain, the non-amyloid-b
component (NAC) domain, and the C-terminal (acidic) domain are highlighted. Charged residues are shown in bold (negative) or underlined (positive).
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with aS variants truncated in the C-terminal domain and com-
plemented our study with AFM imaging. Our results show that
when the complete C-terminus is removed (residues 1e97
remaining in this aS variant), the consequence for the DNA struc-
ture upon aS binding is the opposite to that found upon full-length
aS binding: DNA is compacted instead of extended.2. Materials and methods
2.1. Protein expression and purification
Humanwild-type (aS (1e140)) and truncated (aS (1e97)) aS var-
iantswereheterologouslyexpressedandpurified for the experiments
as described in Ref. [24]. In addition, C-terminal truncated variant, aS
(1e119)was expressed and purified. In short, a pET-21a plasmidwith
the aS (1e119) genewas transformed into BL21 (DE3) (Novagen) cells.
The bacteria were first grown to an OD600 of 0.6 in Luria broth (LB)
containing 100 mg/ml carbenicillin at 37 C and then induced with
1 mM IPTG (isopropyl b-D-1-thiogalactopyranoside) and grown
overnight at 20 C post induction. The cells were harvested and lysed
by sonication on an ice bath in 20 mM Tris-HCl buffer pH 8.0 in the
presence of a protease inhibitor cocktail (Roche). The lysatewas then
heat treated at 90 C in a water bath for 10 min followed by centri-
fugation at 15 000g for 30 min. The supernatant was then filtered
througha0.2mmfilter and loadedonapre-equilibrated 5mlHiTrapQ
FFanion exchange column (GEHealthcare). The proteinwaselutedby
a linear gradient with 1 M NaCl in 20mM Tris-HCl buffer pH 8.0. The
elutedproteinwas runona4e12%SDS-PAGEand fractionscontaining
the protein of interest were pooled and concentrated with Amicon
Ultra-15 10K centrifugal filter units (Millipore). The concentrated
protein was loaded and retrieved from a pre-equilibrated Hiload 16/
600 Superdex 75 pg column (GEHealthcare)with 20mMTris-sulfate
buffer pH 7.4.
Sample purity was confirmed for all aS variants by a single band
on SDS-PAGE gel, a single elution peak in size exclusion chroma-
tography, and by mass spectrometry. Fractions containing pure
protein were pooled and snap frozen in liquid nitrogen and stored
at 80 C. The protein concentration was determined using
ε280 ¼ 5960 M1 cm1 for aS (1e140), and 1490 M1 cm1 for aS
(1e97) and aS (1e119).2.2. Amyloid formation kinetics
The proteins were gel filtered using a superdex 75, 10/300 GL
prepacked column and eluted with Tris-EDTA buffer solution pH 7.4
(10 mM Tris-HCl, 1 mM EDTA, Sigma Aldrich) prior to the aggre-
gation kinetic measurements. A volume of 50 ml/well of each
sample with or without 150 mM NaCl was incubated in non-
binding polystyrene 96-well half-area plates with clear bottom
(Corning Life Sciences) at 37 C in the presence of a borosilicate
glass bead of 2 mm. Thioflavin T fluorescence was monitored every
20 min, with agitation 5 min before each measurement, using a
microplate reader (FLUOstar Optima, BMG Labtech) with excitation44wavelength set at 440 nm and emission wavelength at 480 nm.2.3. Nanofluidics
DNA from phage lambda (l-DNA, Roche) was mixed with each
aS variant and then stained with YOYO-1 (Invitrogen) at a ratio of 1
dye molecule per 25 base pairs in 1  TE (10mM Tris; 1 mM EDTA).
The mixture was incubated at 4 C for at least 2 h. The complexes
were introduced into the nanofluidic system and equilibrated for
60 s before image capture. The DNA concentration was 5 mM
(basepairs) in all samples. 3% (v/v) b-mercaptoethanol (Sigma-
eAldrich) was added as an oxygen scavenger to suppress oxygen
radical induced photo-damage of the DNA. The single DNA mole-
cule experiments were performed in nanochannels with di-
mensions of 150 100 nm2. The devices were fabricated using
advanced nanofabrication described elsewhere [25]. The channel
system consists of a pair of feeding channels (micron sized),
spanned by a set of parallel nanochannels (schematic illustration in
Fig. 3A). The sample was loaded into the channel system from one
of the four reservoirs that are connected to the feeding channels
and moved into the nanochannels by pressure driven (N2) flow. To
avoid non-specific binding of protein to the negatively charged
channel walls, the channels were coated with a lipid bilayer
comprising 99% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC, Avanti) and 1% N-(fluorescein-5-
thiocarbamoyl)-1,2-dihexadecano-yl-sn-Glycero-3-
phosphoethanolamine, triethyl ammonium salt (fluorescein-DHPE,
Invitrogen) prior to the experiment. The coating procedure is
described elsewhere [26].
The DNA and DNA-protein complexes were imaged using an
epi-fluorescence microscope (Zeiss AxioObserver.Z1) equipped
with a Photometrics Evolve EMCCD camera, a 63X oil immersion
TIRF objective (NA ¼ 1.46) and a 1.6X optovar from Zeiss. Using the
microscopy imaging software ZEN, 100 subsequent images were
recorded with an exposure time of 100 ms. Data analysis was
performed using a custom-written MATLAB-based software as
described elsewhere [27].2.4. Atomic force microscopy (AFM)
NoLimits 1000 bp DNA (ThermoFisher Scientific) was mixed
with aS variants at a basepair:protein molar ratio of 15 and the
samples were incubated at 4 C for at least 2 h. 10 ml of each aS-DNA
sample was adsorbed on silicon substrates treated as described
previously [13]. After 10 min adsorption, the wafer was washed
with Milli-Q water and dried using N2 gas. Samples with bare DNA
were prepared on freshly cleaved mica after adding 0.2 mM MgCl2
to 1000 bp DNA (10min adsorption onmica, washwithMilli-Q, and
dried using N2 gas). AFM images were recorded in air, with a
Dimension ICON scanning probe microscope (Bruker) operating in
peak force tapping mode (force constant of 1.45e15.1 Nm1, reso-
nant frequency of 87e230 kHz; scanning rate of 1 Hz). Data analysis
was performed with open-source software Gwyddion (http://
gwyddion.net/).
Fig. 3. Nanofluidic set up and results upon aS addition to DNA. (A) Schematic illustration
of the nanofluidic chip design. The channel system comprises pairs of micro-channels,
spanned by an array of nanochannels (100  150 nm2). The cartoon shows a DNA
moleule confined inside a nanochannel. DNA will be partially stretched along the
nanochannel with an extension Rǀǀ shorter than its contour length L. (B) Relative
extension Rǀǀ/L of l-DNA in the presence of aS (1e140) (C, black), aS (1e119) (-, red)
and aS (1e97) (△, blue) in 1  TE buffer in 150  100 nm2 channels, versus the protein
to DNA base pair (bp) ratio. (C) Representative fluorescence images of l-DNA with aS
variants. Top to bottom: bare DNA, DNA with aS (1e140), DNA with aS (1e119), and
DNA with aS (1e97), each at a protein to base pair ratio of 8:1. The scale bar is 1 mm.
(For interpretation of the references to colour in this figure legend, the reader is
referred to the Web version of this article.)
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Since aS binding to DNA is proposed to be governed in part by
charge-charge interactions [13], we investigated whether the pro-
tein binding was affected by truncation of the aS C-terminal
domain, which would remove negatively charged residues that are
unfavorable for binding to the negatively charged backbone of the
DNA. We studied two C-terminal truncated aS variants: one con-
taining residues 1e97 (aS (1e97)) and another containing residues
1e119 (aS (1e119)), thereby removing 15 and 8 negatively charged
residues from the full-length polypeptide, respectively.
First, we tested that the purified aS variants formed amyloids as
expected. The aggregation kinetics of the two aS variants and full-
length aS (aS (1e140)) were monitored immediately after gel
filtration chromatography to ensure that only protein monomers
were present at the starting point. The aggregation experiments
were performed under agitation in the presence of a glass bead to
increase the reproducibility [28]. Sigmoidal aggregation profiles
were obtained for all variants (30 mM, 37 C, pH 7.4) in the presence
of 150 mM NaCl with a lag phase of around 8 h for aS (1e140), 6 h
for aS (1e119), and 3 h for aS (1e97) (Fig. 2A). Decreasing the ionic
strength (thereby enhancing electrostatic effects) significantly
slowed down the aggregation rate of aS (1e140) (Fig. 2B), but had
no effect on the aggregation of aS (1e97) (Fig. 2C), supporting that
the presence of negatively charged residues in the C-terminal
domain delays aS (1e140) amyloid fibril formation. Importantly,
these experiments showed that aggregation is slow (several hours
of lag phase), even at conditions (glass bead and agitation) that
favor aggregation. aS incubated without agitation does not aggre-
gate at the conditions used here. Therefore, in the nanofluidic
channel experiments, where the samples were mixed without
agitation and measurements were performed within 2 h of sample
preparation, amyloid formation of the aS variants is not expected.
To investigate individual DNA molecules upon binding of the aS
variants, the experimental set up included 48.5 kbp l-DNA (5 mM
base pairs) mixed with a range of aS concentrations (up to 40 mM;
providing 8:1 aS-to-base pair ratio at the highest protein concen-
tration). For such mixtures, we determined the extension of indi-
vidual DNA molecules in nanofluidic channels having a
100  150 nm2 geometry (Fig. 3A). To visualize the DNA, the well-
characterized fluorophore YOYO-1 was used: it binds to DNA via
intercalation between DNA base pairs [29]. The relative extension
Rǀǀ/L (extension Rǀǀ normalized to the DNA contour length L) of DNA
molecules increased with the protein:base pair ratio for full length
aS (1e140) (as reported before [13]) and for aS (1119), but decreased
in the case of aS (1e97) (Fig. 3B; examples in Fig. 3C). Importantly,Fig. 2. Aggregation kinetics of aS variants incubated under agitation in the presence of a glass
blue) samples with 150 mM NaCl. (B) aS (1e140) incubated in the absence (gray) and presen
(blue) of 150 mM NaCl. Three replicates are shown and the protein concentration was 30
referred to the Web version of this article.)
45the changes induced by aS variants (~25% compaction by aS (1e97)
or ~30% extension by aS (1e140) and aS (1e119)) are minor whenbead (37C, pH 7.4). (A) aS (1e140) (C, black), aS (1e119) (-, red) and aS (1e97) (△,
ce of 150 mM NaCl (black); (C) aS (1e97) incubated in the absence (gray) and presence
mM. (For interpretation of the references to colour in this figure legend, the reader is
Fig. 4. AFM analysis of the binding of aS variants to DNA. (A) Tapping mode AFM images of bare DNA (1kbp, 5 mM base pairs) and DNA with aS (1e119) or aS (1e97) at a protein
concentration of 15 mM (3:1 protein:DNA). The scale bar is 100 nm. The line in each panel corresponds to the height profile of the molecule shown in (B). The corresponding
distributions of DNA contour length are shown in (C).
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[30,31]. Another observation is that, for all aS variants, it is possible
to stain the DNA with YOYO-1 even though the DNA is fully coated
with protein, suggesting that binding sites for YOYO-1 are still
available on DNA.
As a complement to the nanochannel data, we turned to atomic
force micrsocopy (AFM) analysis using shorter DNA (1kbp, 5 mM
base pairs) and the aS (1e97) and aS (1e119) variants at a pro-
tein:base pair ratio of 3:1 (Fig. 4A). We found that the DNA height
increased in the presence of both aS variants, from approximately
0.5 nm for bare DNA to 0.7e1.0 nm in the presence of the protein
and the DNA appears to be fully covered by the proteins (Fig. 4B).
This is similar to what we found earlier for aS (1e140) [13].
Whereas the DNA contour length did not change upon aS (1e119)
binding as compared to bare DNA, the DNA contour length
decreased for aS (1e97) (Fig. 4C), which parallels the result of DNA
compaction in the nanochannel.4. Discussion
We here show that C-terminal truncation of aS can induce
changes from extension (over 30% DNA length increase for aS
(1e140) binding and aS (1e119)) to compaction (more than 20%
DNA length decrease for aS (197) binding). Clearly, sufficient
removal of negatively charged residues from aS changes the
resulting structural consequences for DNA upon protein binding.
The most important residues appear to be located between resi-
dues 97 and 119 in the sequence. It appears that upon full C-ter-
minal truncation (43 residues), aS behaves as one expects for
multivalent cation interactions, which often lead to compaction of
DNA. However, we do not observe full compaction of DNA [30,31]
suggesting that the aS-DNA interaction is relatively weak, as is also
reflected by the high concentration of aS needed to saturate the
effect on DNA. The differential result with aS (1e97) reinforces that
the interaction between full-length aS and DNA includes other
forces, such as hydrophobic and/or specific interactions. For a fully
coated DNA it is also possible that protein-protein interactions
between peptides next to each other affect the binding. For full
length aS we concluded that the increase in DNA extensionwas due
to an increase in DNA persistence length [13] and we propose a
similar mechanism for aS (1e119).46Several proteins bind to DNA and affect its structure as a way to
modulate activity, such as gene replication and transcription. For
example, different bacterial nucleoid proteins (e.g., H-NS, Hfq, and
HU) have been shown to specifically compact or extend DNA
[32e34]. To better understand the role of aS-DNA interactions in
PD, underlying molecular principles of such complexes need to be
charcterized. Several proteins and short peptides linked to other
amyloidogenic disorders, including Alzheimer's, Amyotrophic
lateral sclerosis (ALS) and prion diseases, exhibit nucleic acid
binding abilities that may be of functional relevance [35]. Moreover,
liquid-liquid phase separated biological systems often involve
loosely associated -complexes (involving multivalent often elec-
trostatic interactions) between amyloidogenic proteins and RNA
[36,37]. Single DNA molecule techniques, such as the approach
used here, may be useful to characterize putative nucleic-acid
binding of many other proteins involved in both function and
disease.
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